| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.4 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.036 | 0.4 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.047 | 0.4 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.036 | 0.4 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.048 | 0.4 |